Ob/Gyn Groups Oppose Insurer Prior Authorization, Counseling Rules For Genetic Tests
This article was originally published in The Gray Sheet
Executive Summary
Obstetrician/gynecology groups issued a joint statement opposing health insurer requirements for prior authorization and genetic counseling for coverage of frequently used genetic tests to determine breast and ovarian cancer status, including BRCA1 and BRCA2.